Leptin brain entry via a tanycytic LepR-EGFR shuttle controls lipid metabolism and pancreas function.

Leptin brain entry via a tanycytic LepR-EGFR shuttle controls lipid metabolism and pancreas function.
复制标题

DOI:
10.1038/s42255-021-00432-5
复制
发表时间:
2021-08
期刊:
影响因子:
20.8
通讯作者:
Prévot V
Prévot V
中科院分区:
医学1区
文献类型:
--
作者:
Duquenne M;Folgueira C;Bourouh C;Millet M;Silva A;Clasadonte J;Imbernon M;Fernandois D;Martinez-Corral I;Kusumakshi S;Caron E;Rasika S;Deliglia E;Jouy N;Oishi A;Mazzone M;Trinquet E;Tavernier J;Kim YB;Ory S;Jockers R;Schwaninger M;Boehm U;Nogueiras R;Annicotte JS;Gasman S;Dam J;Prévot V

文献摘要

参考文献

被引文献

相似文献

新陈代谢的健康取决于大脑控制食物摄取和营养利用的能力,而不是储存,这一过程需要外围信号,如脂肪细胞衍生的激素,瘦素,以跨越大脑屏障并调动调节电路。我们之前已经证明,下丘脑柔韧细胞将瘦素运送到大脑中,以到达目标神经元。在这里,我们使用多个互补的模型,证明了伸展细胞表达功能性瘦素受体(LepRb),通过触发钙波和靶蛋白磷酸化来响应瘦素,并且它们的跨细胞转运需要瘦素和EGF依次激活Lepr:EGFR复合体。选择性地删除Tanycell中的Lepr会阻止瘦素进入大脑,不仅会增加食物摄入量和脂肪生成,还会通过减少胰腺β细胞的胰岛素分泌而导致葡萄糖不耐受,可能是通过改变交感神经张力。Tanycytic LepRb:因此,EGFR介导的瘦素转运可能在糖尿病的病理生理学中起关键作用,除了肥胖外,还具有治疗意义。
Metabolic health depends on the brain’s ability to control food intake and nutrient use versus storage, processes that require peripheral signals such as the adipocyte-derived hormone, leptin, to cross brain barriers and mobilize regulatory circuits. We have previously shown that hypothalamic tanycytes shuttle leptin into the brain to reach target neurons. Here, using multiple complementary models, we show that tanycytes express functional leptin receptor (LepRb), respond to leptin by triggering Ca2+ waves and target-protein phosphorylation, and that their transcytotic transport of leptin requires the activation of a LepR:EGFR complex by leptin and EGF sequentially. Selectively deleting LepR in tanycytes blocks leptin entry into the brain, inducing not only increased food intake and lipogenesis but glucose intolerance through attenuated insulin secretion by pancreatic β-cells, possibly via altered sympathetic nervous tone. Tanycytic LepRb:EGFR-mediated transport of leptin could thus be crucial to the pathophysiology of diabetes in addition to obesity, with therapeutic implications.
DOI: 10.1146/annurev-biochem-072909-095555
发表时间: 2012
影响因子: 16.6
作者:
Back SH;Kaufman RJ
通讯作者: Kaufman RJ
如何计算医学研究中不同研究设计的样本量?
DOI: 10.4103/0253-7176.116232
发表时间: 2013-04
影响因子: 2.8
作者:
Charan J;Biswas T
通讯作者: Biswas T
DOI: 10.1210/en.2009-0870
发表时间: 2010-04-01
期刊: ENDOCRINOLOGY
影响因子: 4.8
作者:
de Seranno, Sandrine;de Tassigny, Xavier d'Anglemont;Prevot, Vincent
通讯作者: Prevot, Vincent
DOI: 10.1016/j.cmet.2013.12.015
发表时间: 2014-02-04
期刊: Cell metabolism
影响因子: 29
作者:
Balland E;Dam J;Langlet F;Caron E;Steculorum S;Messina A;Rasika S;Falluel-Morel A;Anouar Y;Dehouck B;Trinquet E;Jockers R;Bouret SG;Prévot V
通讯作者: Prévot V
DOI: 10.1172/jci117864
发表时间: 1995-04-01
影响因子: 15.9
作者:
COLBERG, SR;SIMONEAU, JA;KELLEY, DE
通讯作者: KELLEY, DE